Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 251

Results For "SPI"

2623 News Found

NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19
Drug Approval | August 10, 2021

NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19

Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant


Govt. to open 10,500 Janaushadhi Kendras: Mandaviya
Healthcare | August 09, 2021

Govt. to open 10,500 Janaushadhi Kendras: Mandaviya

The government has recently enhanced the incentive granted to storeowners from existing Rs. 2.50 lakh to Rs. 5.00 lakh given at the rate of 15% of monthly purchases made, subject to a ceiling of Rs. 15,000 per month


Novavax announces COVID-19 vaccine booster data indicating four-fold increase in neutralising antibodies
Biotech | August 09, 2021

Novavax announces COVID-19 vaccine booster data indicating four-fold increase in neutralising antibodies

Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series


FDA approves Nexviazyme for late-onset Pompe disease
Drug Approval | August 09, 2021

FDA approves Nexviazyme for late-onset Pompe disease

Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells


India's doctor-population ratio to reach WHO benchmark soon: Dr Vinod Paul
Healthcare | August 09, 2021

India's doctor-population ratio to reach WHO benchmark soon: Dr Vinod Paul

By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas


Strides Pharma reports Q1FY22 consolidated loss at Rs 205.2 Cr
Biotech | August 08, 2021

Strides Pharma reports Q1FY22 consolidated loss at Rs 205.2 Cr

The company expects revenue growth of 10-15 per cent in the US


Cipla posts  net profit at Rs 715 crores
News | August 08, 2021

Cipla posts net profit at Rs 715 crores

India business contributes to a stellar performance


Bafna Pharma posts Q1FY 21-22 net at Rs. 2.08 Cr
News | August 07, 2021

Bafna Pharma posts Q1FY 21-22 net at Rs. 2.08 Cr

This robust growth has come despite the raging pandemic for most part of the quarter


Scientists from BRICS work on genomic sequencing of Covid-19
Drug Approval | August 06, 2021

Scientists from BRICS work on genomic sequencing of Covid-19

Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread